1Abgrall S, Rabaud C, Costagliola D. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis, 2001,33:1747 -1755.
2UNAIDS. AIDS epidemic update: December 2007. March 2008. http://www, unaids, org/en/KnowledgeCentre/ HIVData/EpiUpdate/EpiUpdArchive/2007/default. asp (accessed Oct 21, 2009).
3Levy JA. HIV and the Pathogenesis of AIDS. 2rd ed. Washington, DC: ASM Press, 1988.
4John G, Bartlett MD, Joel E,et al. Medical Management of HIV Infection. 2004.
5Barr4-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquiredimmune deficiency syndrome (AIDS). Seience, 1983,220:868-871.
6Graf M, Shao Y, Zhao Q,et al. Cloning and characterization of a virtually full-length HIV type 1 genome from a subtypeB- Thai strain representing the most prevalent B clade isolate in China. AIDSRes HumRetroviruses, 1998,14:285-288.
7中国疾病预防控制中心.全国艾滋病检测技术规范.2004年8月.
8Dragic T, Litwin V, Allaway GP, et al. HIV-I entry into CD4+ ceils is mediated by the chemokine receptor CC-CKR 5. Nature, 1996,381:667-673.
9Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med, 1995,333:751-756.
10Ho DD, Neumann AU, Perelson AS,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 1995,373:123-126.
